Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components

키워드

참고문헌 (154)

1. Su Z, "Phytochemicals : targeting mitophagy to treat metabolic disorders", Front Cell Dev Biol, 9, pp.686820~ (2021)
2. Bacanli M, "Effects of phytochemicals against diabetes", Adv Food Nutr Res, 89, pp.209~238 (2019)
3. Morais JB, "Role of magnesium in oxidative stress in individuals with obesity", Biol Trace Elem Res, 176, pp.20~26 (2017)
4. Hu F, "Mitochondrial stress : a bridge between mitochondrial dysfunction and metabolic diseases?", Cell Signal, 23, pp.1528~1533 (2011)
5. Bhatti JS, "Mitochondrial dysfunction and oxidative stress in metabolic disorders-a step towards mitochondria based therapeutic strategies", Biochim Biophys Acta BBAMol Basis Dis, 1863, pp.1066~1077 (2017)
6. Nicolson GL, "Mitochondrial dysfunction and chronic disease : treatment with natural supplements", Integr Med(Encinitas), 13, pp.35~43 (2014)
7. Tian HY, "The interplay between mitochondrial dysfunction and ferroptosis during ischemia-associated central nervous system diseases", Brain Sci, 13, pp.1367~ (2023)
8. Kusminski CM, "Mitochondrial dysfunction in white adipose tissue", Trends Endocrinol Metab, 23, pp.435~443 (2012)
9. Paradies G, "Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease", World J Gastroenterol, 20, pp.14205~14218 (2014)
10. Mansouri A, "Mitochondrial dysfunction and signaling in chronic liver diseases", Gastroenterology, 155, pp.629~647 (2018)
11. Smith RA, "Selective targeting of an antioxidant to mitochondria", Eur J Biochem, 263, pp.709~716 (1999)
12. Wang B, "Resveratrol preserves mitochondrial function, stimulates mitochondrial biogenesis, and attenuates oxidative stress in regulatory T cells of mice fed a high-fat diet", J Food Sci, 79, pp.H1823~ (2014)
13. Kobori M, "Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice", Mol Nutr Food Res, 60, pp.300~312 (2016)
14. Xu Z, "Coenzyme Q10 improves lipid metabolism and ameliorates obesity by regulating CaMKII-mediated PDE4 inhibition", Sci Rep, 7, pp.8253~ (2017)
15. Buettner C, "Effects of coenzyme Q10 on skeletal muscle oxidative metabolism in statin users assessed using 31P magnetic resonance spectroscopy : a randomized controlled study", J Nat Sci, 2, pp.e212~ (2016)
16. Shishodia S, "Curcumin : getting back to the roots", Ann N Y Acad Sci, 1056, pp.206~217 (2005)
17. Yang Y, "Astaxanthin structure, metabolism, and health benefits", J Hum Nutr Food Sci, 1, pp.1003~ (2013)
18. Zhang H, "Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects", Current Opinion in Food Science, 8, pp.33~42 (2016)
19. Mantzorou M, "Effects of curcumin consumption on human chronic diseases : a narrative review of the most recent clinical data", Phytother Res, 32, pp.957~975 (2018)
20. Gutierrez-Mariscal FM, "Coenzyme Q10 : from bench to clinic in aging diseases, a translational review", Crit Rev Food Sci Nutr, 59, pp.2240~2257 (2019)
21. Farruggia C, "Astaxanthin exerts anti-inflammatory and antioxidant effects in macrophages in NRF2-dependent and independent manners", J Nutr Biochem, 62, pp.202~209 (2018)
22. Bullon P, "Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis : a shared pathology via oxidative stress and mitochondrial dysfunction?", Periodontol 2000, 64, pp.139~153 (2014)
23. Turner N, "Developmental programming of obesity and insulin resistance : does mitochondrial dysfunction in oocytes play a role?", Mol Hum Reprod, 21, pp.23~30 (2015)
24. Becker T, "Mitochondrial outer membrane channels : emerging diversity in transport processes", BioEssays, 40, pp.e1800013~ (2018)
25. Seifert EL, "The mitochondrial phosphate carrier : role in oxidative metabolism, calcium handling and mitochondrial disease", Biochem Biophys Res Commun, 464, pp.369~375 (2015)
26. Cserép C, "Mitochondrial ultrastructure is coupled to synaptic performance at axonal release sites", eNeuro, 5, pp.ENEURO.0390-17.2018~ (2018)
27. Bogenhagen DF, "Mitochondrial DNA nucleoid structure", Biochim Biophys Acta, 1819, pp.914~920 (2012)
28. Wallace DC, "The mitochondrial genome in human adaptive radiation and disease : on the road to therapeutics and performance enhancement", Gene, 354, pp.169~180 (2005)
29. Bournat JC, "Mitochondrial dysfunction in obesity", Curr Opin Endocrinol Diabetes Obes, 17, pp.446~452 (2010)
30. Li PA, "Mitochondrial biogenesis in neurodegeneration", J Neurosci Res, 95, pp.2025~2029 (2017)
31. Forbes-Hernández TY, "The effects of bioactive compounds from plant foods on mitochondrial function : a focus on apoptotic mechanisms", Food Chem Toxicol, 68, pp.154~182 (2014)
32. Ventura-Clapier R, "Transcriptional control of mitochondrial biogenesis : the central role of PGC-1α", Cardiovasc Res, 79, pp.208~217 (2008)
33. Scarpulla RC, "Transcriptional paradigms in mammalian mitochondrial biogenesis and function", Physiol Rev, 88, pp.611~638 (2008)
34. Scarpulla RC, "Transcriptional integration of mitochondrial biogenesis", Trends Endocrinol Metab, 23, pp.459~466 (2012)
35. Vega RB, "The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes", Mol Cell Biol, 20, pp.1868~1876 (2000)
36. Prasun P, "Mitochondrial dysfunction in metabolic syndrome", Biochim Biophys Acta Mol Basis Dis, 1866, pp.165838~ (2020)
37. Cantó C, "PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure", Curr Opin Lipidol, 20, pp.98~105 (2009)
38. Herzig S, "AMPK : guardian of metabolism and mitochondrial homeostasis", Nat Rev Mol Cell Biol, 19, pp.121~135 (2018)
39. Majeed Y, "SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways", Sci Rep, 11, pp.8177~ (2021)
40. Price NL, "SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function", Cell Metab, 15, pp.675~690 (2012)
41. Ruderman NB, "AMPK and SIRT1 : a long-standing partnership?", Am J Physiol Endocrinol Metab, 298, pp.E751~ (2010)
42. Lan F, "SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation", J Biol Chem, 283, pp.27628~27635 (2008)
43. Valle I, "PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells", Cardiovasc Res, 66, pp.562~573 (2005)
44. Mottis A, "The mitochondrial unfolded protein response in mammalian physiology", Mamm Genome, 25, pp.424~433 (2014)
45. Martinus RD, "Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome", Eur J Biochem, 240, pp.98~103 (1996)
46. Zhao Q, "A mitochondrial specific stress response in mammalian cells", EMBO J, 21, pp.4411~4419 (2002)
47. Haynes CM, "The mitochondrial UPR-protecting organelle protein homeostasis", J Cell Sci, 123, pp.3849~3855 (2010)
48. Zhu L, "Mitochondrial unfolded protein response : a novel pathway in metabolism and immunity", Pharmacol Res, 168, pp.105603~ (2021)
49. Bhaskaran S, "A fish oil diet induces mitochondrial uncoupling and mitochondrial unfolded protein response in epididymal white adipose tissue of mice", Free Radic Biol Med, 108, pp.704~714 (2017)
50. Kleinridders A, "Leptin regulation of Hsp60 impacts hypothalamic insulin signaling", J Clin Invest, 123, pp.4667~4680 (2013)
51. Lee HJ, "Downregulation of mitochondrial Lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1 cells", Diabetologia, 54, pp.1437~1446 (2011)
52. Gariani K, "Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice", Hepatology, 63, pp.1190~1204 (2016)
53. Brand MD, "Assessing mitochondrial dysfunction in cells", Biochem J, 435, pp.297~312 (2011)
54. Pieczenik SR, "Mitochondrial dysfunction and molecular pathways of disease", Exp Mol Pathol, 83, pp.84~92 (2007)
55. Murphy MP, "How mitochondria produce reactive oxygen species", Biochem J, 417, pp.1~13 (2009)
56. De Pauw A, "Mitochondrial(dys)function in adipocyte(de)differentiation and systemic metabolic alterations", Am J Pathol, 175, pp.927~939 (2009)
57. Abdul-Ghani MA, "Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus", Curr Diab Rep, 8, pp.173~178 (2008)
58. Wang K, "Mitochondria removal by autophagy", Autophagy, 7, pp.297~300 (2011)
59. Finck BN, "Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis", Diabetes, 67, pp.2485~2493 (2018)
60. Kudryavtseva AV, "Mitochondrial dysfunction and oxidative stress in aging and cancer", Oncotarget, 7, pp.44879~44905 (2016)
61. Ning P, "Mitophagy : a potential therapeutic target for insulin resistance", Front Physiol, 13, pp.957968~ (2022)
62. Wu H, "Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome", Autophagy, 15, pp.1882~1898 (2019)
63. Deas E, "Mitophagy and Parkinson’s disease : the PINK1-parkin link", Biochim Biophys Acta, 1813, pp.623~633 (2011)
64. O’Sullivan TE, "BNIP3-and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory", Immunity, 43, pp.331~342 (2015)
65. Balan E, "Regular endurance exercise promotes fission, mitophagy, and oxidative phosphorylation in human skeletal muscle independently of age", Front Physiol, 10, pp.1088~ (2019)
66. Hernández-Aguilera A, "Mitochondrial dysfunction : a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities", Mediators Inflamm, 2013, pp.135698~ (2013)
67. Gao CL, "Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes", Mol Cell Endocrinol, 320, pp.25~33 (2010)
68. Chen XH, "TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes", Mol Cell Endocrinol, 328, pp.63~69 (2010)
69. Furukawa S, "Increased oxidative stress in obesity and its impact on metabolic syndrome", J Clin Invest, 114, pp.1752~1761 (2004)
70. Vankoningsloo S, "Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells : role of fatty acid β-oxidation and glucose", J Lipid Res, 46, pp.1133~1149 (2005)
71. Kaplan RS, "Structure, function and regulation of the tricarboxylate transport protein from rat liver mitochondria", J Bioenerg Biomembr, 25, pp.503~514 (1993)
72. Kajimoto K, "Essential role of citrate export from mitochondria at early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells, as revealed by studies using specific inhibitors of mitochondrial di-and tricarboxylate carriers", Mol Genet Metab, 85, pp.46~53 (2005)
73. Vankoningsloo S, "CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes", J Cell Sci, 119, pp.1266~1282 (2006)
74. Wilson-Fritch L, "Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone", Mol Cell Biol, 23, pp.1085~1094 (2003)
75. Kruszynska YT, "Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects", Diabetes, 47, pp.1107~1113 (1998)
76. Højlund K, "Mitochondrial dysfunction in type 2 diabetes and obesity", Endocrinol Metab Clin North Am, 37, pp.713~731 (2008)
77. Kim JA, "Role of mitochondrial dysfunction in insulin resistance", Circ Res, 102, pp.401~414 (2008)
78. Jha D, "High fat diet administration leads to the mitochondrial dysfunction and selectively alters the expression of class 1 GLUT protein in mice", Mol Biol Rep, 46, pp.1727~1736 (2019)
79. Lim JH, "Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells", Diabetologia, 49, pp.1924~1936 (2006)
80. Houstis N, "Reactive oxygen species have a causal role in multiple forms of insulin resistance", Nature, 440, pp.944~948 (2006)
81. Rong JX, "Adipose mitochondrial biogenesis is suppressed in db", db and high-fat diet-fed mice and improved by rosiglitazone, 2007, pp.56, 1751~1760
82. Samocha-Bonet D, "Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans", PLoS One, 7, pp.e36320~ (2012)
83. Lowell BB, "Mitochondrial dysfunction and type 2 diabetes", Science, 307, pp.384~387 (2005)
84. Bogacka I, "Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo", Diabetes, 54, pp.1392~1399 (2005)
85. Nassir F, "Role of mitochondria in nonalcoholic fatty liver disease", Int J Mol Sci, 15, pp.8713~8742 (2014)
86. Begriche K, "Mitochondrial dysfunction in NASH : causes, consequences and possible means to prevent it", Mitochondrion, 6, pp.1~28 (2006)
87. Wei Y, "Nonalcoholic fatty liver disease and mitochondrial dysfunction", World J Gastroenterol, 14, pp.193~199 (2008)
88. Westerbacka J, "Genes involved in fatty acid partitioning and binding, lipolysis, monocyte", macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects, 2007, pp.56, 2759~2765
89. Besse-Patin A, "Estrogen signals through peroxisome proliferator-activated receptor-γ coactivator 1α to reduce oxidative damage associated with diet-induced fatty liver disease", Gastroenterology, 152, pp.243~256 (2017)
90. Handa P, "Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis", Hepatology, 60, pp.133~145 (2014)
91. Santamaría E, "Functional proteomics of nonalcoholic steatohepatitis : mitochondrial proteins as targets of S-adenosylmethionine", Proc Natl Acad Sci U S A, 100, pp.3065~3070 (2003)
92. Pérez-Carreras M, "Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis", Hepatology, 38, pp.999~1007 (2003)
93. Frąk W, "Pathophysiology of cardiovascular diseases : new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease", Biomedicines, 10, pp.1938~ (2022)
94. Chistiakov DA, "The role of mitochondrial dysfunction in cardiovascular disease : a brief review", Ann Med, 50, pp.121~127 (2018)
95. Kattoor AJ, "Oxidative stress in atherosclerosis", Curr Atheroscler Rep, 19, pp.42~ (2017)
96. Ballinger SW, "Mitochondrial dysfunction in cardiovascular disease", Free Radic Biol Med, 38, pp.1278~1295 (2005)
97. Corral-Debrinski M, "Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease", Mutat Res, 275, pp.169~180 (1992)
98. Tsutsui H, "Oxidative stress and mitochondrial DNA damage in heart failure", Circ J, 72(Suppl A), pp.A31~A37 (2008)
99. Ide T, "Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium", Circ Res, 85, pp.357~363 (1999)
100. Ide T, "Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction", Circ Res, 88, pp.529~535 (2001)
101. Ballinger SW, "Mitochondrial integrity and function in atherogenesis", Circulation, 106, pp.544~549 (2002)
102. Blanc J, "Protective role of uncoupling protein 2 in atherosclerosis", Circulation, 107, pp.388~390 (2003)
103. Suematsu N, "Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes", Circulation, 107, pp.1418~1423 (2003)
104. Timmers S, "Therapeutic potential of resveratrol in obesity and type 2 diabetes : new avenues for health benefits?", Ann N Y Acad Sci, 1290, pp.83~89 (2013)
105. Brenmoehl J, "Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3", Mitochondrion, 13, pp.755~761 (2013)
106. Bai L, "Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes", Mol Cell Biochem, 307, pp.129~140 (2008)
107. Rayalam S, "Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes", Phytother Res, 22, pp.1367~1371 (2008)
108. Lagouge M, "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α", Cell, 127, pp.1109~1122 (2006)
109. Beaudoin MS, "Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats", Am J Physiol Regul Integr Comp Physiol, 305, pp.R542~ (2013)
110. Menzies KJ, "Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis", J Biol Chem, 288, pp.6968~6979 (2013)
111. Desquiret-Dumas V, "Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells", J Biol Chem, 288, pp.36662~36675 (2013)
112. Shin SM, "Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway", Mol Pharmacol, 76, pp.884~895 (2009)
113. Baur JA, "Resveratrol improves health and survival of mice on a high-calorie diet", Nature, 444, pp.337~342 (2006)
114. Berridge MJ, "Calcium signalling : dynamics, homeostasis and remodelling", Nat Rev Mol Cell Biol, 4, pp.517~529 (2003)
115. Yang JY, "Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin", Life Sci, 82, pp.1032~1039 (2008)
116. Maurya AK, "Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase(PI3K)and protein kinase C(PKC)via induction of p53 in hepatocellular carcinoma(HepG2)cell line", Mol Biol Rep, 42, pp.1419~1429 (2015)
117. Kim GT, "Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner", Int J Mol Med, 33, pp.863~869 (2014)
118. Bishayee K, "Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2", M, in cervical carcinoma : signal cascade and drug-DNA interaction, 2013, pp.46, 153~163
119. Zhou B, "Quercetin inhibits DNA damage responses to induce apoptosis via SIRT5", PI3K, Biomed Pharmacother, pp.2023, 165[DOI]
120. Gulati N, "The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt", PKB pathway, 2006, pp.26, 1177~1181
121. Huang CY, "Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells", J Nutr Biochem, 24, pp.1596~1603 (2013)
122. Jeong JH, "Quercetin-induced ubiquitination and down-regulation of Her-2", neu, 2008, pp.105, 585~595
123. Vidya Priyadarsini R, "The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer(HeLa)cells through p53 induction and NF-κB inhibition", Eur J Pharmacol, 649, pp.84~91 (2010)
124. Sun ZJ, "Activation of PI3K", Akt, NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma : its inhibition by quercetin, pp.Apoptosis, 2010[DOI]
125. Henagan TM, "Dietary quercetin supplementation in mice increases skeletal muscle PGC1α expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner", PLoS One, 9, pp.e89365~ (2014)
126. Devarshi PP, "Quercetin and quercetin-rich red onion extract alter Pgc-1α promoter methylation and splice variant expression", PPAR Res, 2017, pp.3235693~ (2017)
127. Rayamajhi N, "Quercetin induces mitochondrial biogenesis through activation of HO-1 in HepG2 cells", Oxid Med Cell Longev, 2013, pp.154279~ (2013)
128. Kim CS, "Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1", Nutr Metab(Lond), 12, pp.33~ (2015)
129. Ma X, "Role and mechanisms of mitophagy in liver diseases", Cells, 9, pp.837~ (2020)
130. Liu P, "Frataxin-mediated PINK1-Parkin-dependent mitophagy in hepatic steatosis : the protective effects of quercetin", Mol Nutr Food Res, 62, pp.e1800164~ (2018)
131. Wang WW, "Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson’s disease models", Aging(Albany NY), 13, pp.11738~11751 (2021)
132. Quinzii CM, "Coenzyme Q and mitochondrial disease", Dev Disabil Res Rev, 16, pp.183~188 (2010)
133. Hidalgo-Gutiérrez A, "Metabolic targets of coenzyme Q10 in mitochondria", Antioxidants, 10, pp.520~ (2021)
134. Carmona MC, "Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob", ob mice, 2009, pp.33, 204~211
135. Fazakerley DJ, "Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance", eLife, 7, pp.e32111~ (2018)
136. Ogasahara S, "Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy", Proc Natl Acad Sci U S A, 86, pp.2379~2382 (1989)
137. Lalani SR, "Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency", Arch Neurol, 62, pp.317~320 (2005)
138. Marcoff L, "The role of coenzyme Q10 in statin-associated myopathy : a systematic review", J Am Coll Cardiol, 49, pp.2231~2237 (2007)
139. Tian G, "Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice", Antioxid Redox Signal, 20, pp.2606~2620 (2014)
140. Mohammadi-Bardbori A, "Coenzyme Q10 remarkably improves the bio-energetic function of rat liver mitochondria treated with statins", Eur J Pharmacol, 762, pp.270~274 (2015)
141. Stansfield WE, "Cellular and molecular pathobiology of cardiovascular disease", pp.51~78 (2014), Elsevier
142. Lone J, "Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes", J Nutr Biochem, 27, pp.193~202 (2016)
143. Wang S, "Curcumin promotes browning of white adipose tissue in a norepinephrine-dependent way", Biochem Biophys Res Commun, 466, pp.247~253 (2015)
144. Kim SW, "Proteomic identification of fat-browning markers in cultured white adipocytes treated with curcumin", Mol Cell Biochem, 415, pp.51~66 (2016)
145. He HJ, "Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice", World J Diabetes, 3, pp.94~104 (2012)
146. Ray Hamidie RD, "Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels", Metabolism, 64, pp.1334~1347 (2015)
147. Zhang J, "Curcumin attenuates D-galactosamine", lipopolysaccharide-induced liver injury and mitochondrial dysfunction in mice, 2014, pp.144, 1211~1218
148. Kuo JJ, "Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis", Int J Mol Med, 30, pp.673~679 (2012)
149. Soto-Urquieta MG, "Curcumin restores mitochondrial functions and decreases lipid peroxidation in liver and kidneys of diabetic db", db mice, 2014, pp.47, 74~
150. Kuo JJ, "Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis", Int J Mol Med, 30, pp.643~649 (2012)
151. Jia Y, "Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL", 6J mice via activation of peroxisome proliferator-activated receptor(PPAR)alpha and inhibition of PPAR gamma and Akt, 2016, pp.28, 9~18
152. Kim B, "Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis", J Nutr Biochem, 43, pp.27~35 (2017)
153. Liu PH, "The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by a PGC-1α increase in skeletal muscle", J Clin Biochem Nutr, 54, pp.86~89 (2014)
154. Henagan TM, "In vivo effects of dietary quercetin and quercetin-rich red onion extract on skeletal muscle mitochondria, metabolism, and insulin sensitivity", Genes Nutr, 10, pp.451~ (2015)

관련 논문AI추천